SSA published SSR
            17-3p, “Evaluating Cases Involving Sickle Cell Disease (SCD)” on September 15, 2017. This
            Social Security Ruling (SSR), which took effect upon publication, provides guidance
            for assessing SCD under the hematological disorder listings and determining how this
            impairment may affect the residual functional capacity finding for adults and the
            functional equivalence finding for children.